Latest News

The recent earnings posted by Compañía Española de Viviendas en Alquiler S.A. ( BME:CEV ) were solid, but the stock...

Tiv Taam Holdings 1 Ltd. ( TLV:TTAM ) just reported healthy earnings but the stock price didn't move much. Investors...

The Asian market has been navigating a complex landscape, influenced by geopolitical tensions and fluctuating energy prices, which have significantly impacted investor sentiment and led to mixed performances across various indices. Amid these challenges, high growth tech stocks in Asia continue to attract attention due to their potential for innovation and resilience in adapting to changing market dynamics.

As global markets grapple with energy price volatility and geopolitical tensions, Asian equities have been influenced by these broader economic pressures, prompting investors to reassess valuations across the region. In this environment, identifying stocks trading below their estimated intrinsic value can provide opportunities for investors seeking potential growth amidst uncertainty.

A lackluster earnings announcement from Artifex Mundi S.A. ( WSE:ART ) last week didn't sink the stock price. Our...

Soltec Power Holdings, S.A.'s ( BME:SOL ) healthy profit numbers didn't contain any surprises for investors. We think...

As Asian markets navigate the complexities of energy price volatility and geopolitical tensions, investors are increasingly focused on identifying resilient growth opportunities. In this environment, companies with high insider ownership can be particularly appealing, as they often signal strong alignment between management and shareholder interests.

Amidst the backdrop of Middle East conflict and energy price volatility, Asian markets have been navigating a complex economic landscape. These conditions underscore the importance of identifying stocks with robust fundamentals, especially in less traditional areas like penny stocks. Although often seen as relics from past market eras, penny stocks still offer intriguing growth opportunities by representing smaller or newer companies that can surprise investors with their potential for strong...

The subdued stock price reaction suggests that Mowi ASA's ( OB:MOWI ) strong earnings didn't offer any surprises. Our...

As geopolitical tensions and energy price volatility ripple through global markets, Asian equities are navigating a complex landscape with both challenges and opportunities. Amidst this backdrop, the S&P MidCap 400 and Russell 2000 indexes have shown resilience, highlighting the potential for small-cap stocks to thrive in uncertain times. In such an environment, identifying strong fundamentals and growth potential can be key to uncovering undiscovered gems that might enhance a diversified...

Readers hoping to buy More Provident Funds and Pensions Ltd ( TLV:MPP ) for its dividend will need to make their move...

Amidst the backdrop of geopolitical tensions and fluctuating energy prices, Asian markets are navigating a complex landscape that has left investors assessing both risks and opportunities. In this environment, dividend stocks offer a potential avenue for stability and income, as companies with strong fundamentals and consistent payout histories can provide a buffer against market volatility.

Looking at Impero A/S' ( CPH:IMPERO ) insider transactions over the last year, we can see that insiders were net...

The market seemed underwhelmed by last week's earnings announcement from Somec S.p.A. ( BIT:SOM ) despite the healthy...

Allied Gold (TSX:AAUC) has closed out FY 2025 with fourth quarter revenue of US$427.8 million and a basic EPS loss of US$0.19, while trailing twelve month figures show revenue of about US$1.3 billion and a basic EPS loss of US$0.45. The company has seen quarterly revenue move from US$170.8 million in Q4 2024 to US$427.8 million in Q4 2025, with basic EPS shifting from a loss of US$0.09 to a loss of US$0.19 over the same period. This keeps the focus firmly on how quickly margins can move...

Why TC Energy (TSX:TRP) Is Back on Investor Radar TC Energy (TSX:TRP) has drawn fresh attention after issuing 2026 guidance that includes projected comparable EBITDA of $11.6 billion to $11.8 billion and higher comparable EPS than 2025, alongside active analyst coverage. See our latest analysis for TC Energy. TC Energy's guidance and higher profile in LNG discussions come after a strong run, with a 14.36% 90 day share price return and a 29.36% 1 year total shareholder return, suggesting...

HCA Healthcare recently announced that the HCA Healthcare Foundation will provide a US$2.00 million grant to Second Harvest Food Bank of Middle Tennessee to support its new Grow for Good campus in Nashville, alongside highlighting a mixed quarterly report with revenue slightly below expectations but earnings per share ahead of forecasts. The combination of continued investment in network expansion and workforce development, together with community-focused initiatives like Grow for Good,...

In March 2026, Synopsys, Inc. announced a multi-billion-dollar private placement of common shares with participation from new investor Elliott Investment Management L.P., and earlier that month Arm revealed a collaboration with Synopsys on the Arm AGI CPU using Synopsys’ full-stack design tools and IP. This combination of fresh capital and deeper alignment with Arm’s Neoverse ecosystem highlights Synopsys’ role in enabling next-generation custom silicon and complex compute systems. Next,...

In March 2026, Synchrony Financial announced a partnership with Figo Pet Insurance that lets pet owners use CareCredit to pay upfront vet bills and receive approved insurance reimbursements directly as credits to their CareCredit accounts. This integration expands CareCredit’s pet insurance reimbursement ecosystem to more than 1.20 billion insured policyholders across Figo, Pets Best, and Pumpkin, simplifying veterinary payments for customers and clinics. Next, we’ll examine how this...

In the first quarter of 2026, Hamamatsu Photonics K.K. completed a board-approved buyback of 7,662,800 shares for ¥13,010.92 million, while Sakura Finetek and Hamamatsu announced an alliance to create a seamless workflow from tissue preparation to digital pathology imaging. Together, these moves highlight Hamamatsu’s focus on integrating its imaging technology into clinical diagnostics workflows while actively returning capital to shareholders through repurchases. We’ll now examine how...

AirSculpt Technologies (AIRS) has wrapped up FY 2025 with Q4 revenue of US$33.4 million and net income of US$1.3 million, translating to basic EPS of US$0.02. Over the trailing twelve months, the company reported revenue of US$151.8 million and a net loss of US$11.7 million, or a basic EPS loss of US$0.19. During FY 2025, quarterly revenue ranged from US$33.4 million to US$44.0 million, while basic EPS moved between a loss of US$0.15 and a small profit of US$0.02. This puts the latest quarter...

In late March 2026, IonQ’s shares weakened as heightened geopolitical tensions in the Middle East, particularly the conflict with Iran, weighed on broader equity markets and dampened risk appetite. At the same time, IonQ’s memorandum of understanding with South Korea’s KISTI to integrate its quantum systems with local high-performance computing highlights the company’s growing role in global quantum infrastructure and workforce development. Against this backdrop, we’ll explore how...

Tarsus Pharmaceuticals (TARS) has drawn fresh attention after dosing the first participant in its Phase 2 Calliope trial of TP-05, an oral candidate aimed at preventing Lyme disease by killing infected ticks. See our latest analysis for Tarsus Pharmaceuticals. The recent TP-05 progress and TP-03 milestone in China come as the share price sits at US$70.22, with a 7 day share price return of 4.9% but a 90 day share price return showing a 14.2% decline. The 1 year total shareholder return of...

If you are wondering whether Legend Biotech's share price reflects its underlying value, this article breaks down what the current market price may be implying about the company. The stock closed at US$19.05, with returns of 8.2% over the last week and 3.3% over the last month. The 1 year return stands at a 42.7% decline and the 3 year return at a 60.5% decline. Recent coverage around Legend Biotech has focused on its position in the biotech space and how investors are reassessing risk and...